Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis	Hemic and Lymphatic Diseases, Myeloproliferative Disorders, bone marrow disorder, hematologic disorder, primary myelofibrosis	Recruiting	Phase 2	2026-07-20		NCT04370301

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Fred Hutchinson Cancer Center	123

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Fred Hutch/University of Washington Cancer Consortium	Seattle	United States	140

Clinical trials